BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10593450)

  • 1. Measuring neuroleptic-induced akathisia by three-channel actometry.
    Tuisku K; Lauerma H; Holi M; Markkula J; Rimon R
    Schizophr Res; 1999 Nov; 40(2):105-10. PubMed ID: 10593450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia.
    Janno S; Holi MM; Tuisku K; Wahlbeck K
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):39-41. PubMed ID: 15572272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisocial violent offenders with attention deficit hyperactivity disorder demonstrate akathisia-like hyperactivity in three-channel actometry.
    Tuisku K; Virkkunen M; Holi M; Lauerma H; Naukkarinen H; Rimon R; Wahlbeck K
    J Neuropsychiatry Clin Neurosci; 2003; 15(2):194-9. PubMed ID: 12724461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-induced akathisia].
    van Harten PN
    Ned Tijdschr Geneeskd; 2002 Jan; 146(3):110-4. PubMed ID: 11826669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia.
    Poyurovsky M; Nave R; Epstein R; Tzischinsky O; Schneidman M; Barnes TR; Weizman A; Lavie P
    Eur Neuropsychopharmacol; 2000 May; 10(3):171-6. PubMed ID: 10793319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe akathisia during olanzapine treatment of acute schizophrenia.
    Jauss M; Schröder J; Pantel J; Bachmann S; Gerdsen I; Mundt C
    Pharmacopsychiatry; 1998 Jul; 31(4):146-8. PubMed ID: 9754850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome.
    Walters AS; Hening W; Rubinstein M; Chokroverty S
    Sleep; 1991 Aug; 14(4):339-45. PubMed ID: 1682986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggression, agitation, and mania with olanzapine.
    John V; Rapp M; Pies R
    Can J Psychiatry; 1998 Dec; 43(10):1054. PubMed ID: 9868577
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential sensitivities to risperidone and olanzapine in a human immunodeficiency virus patient.
    Meyer JM; Marsh J; Simpson G
    Biol Psychiatry; 1998 Oct; 44(8):791-4. PubMed ID: 9798086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study.
    Lerner V; Bergman J; Statsenko N; Miodownik C
    J Clin Psychiatry; 2004 Nov; 65(11):1550-4. PubMed ID: 15554771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.
    Stryjer R; Rosenzcwaig S; Bar F; Ulman AM; Weizman A; Spivak B
    Clin Neuropharmacol; 2010; 33(5):219-22. PubMed ID: 20838215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study.
    Miodownik C; Lerner V; Statsenko N; Dwolatzky T; Nemets B; Berzak E; Bergman J
    Clin Neuropharmacol; 2006; 29(2):68-72. PubMed ID: 16614537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic-induced movement disorders in a naturalistic schizophrenia population: diagnostic value of actometric movement patterns.
    Janno S; Holi MM; Tuisku K; Wahlbeck K
    BMC Neurol; 2008 Apr; 8():10. PubMed ID: 18419829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akathisia masked by hypokinesia.
    Tuisku K; Lauerma H; Holi MM; Honkonen T; Rimon R
    Pharmacopsychiatry; 2000 Jul; 33(4):147-9. PubMed ID: 10958265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol treatment of olanzapine-induced akathisia.
    Kurzthaler I; Hummer M; Kohl C; Miller C; Fleischhacker WW
    Am J Psychiatry; 1997 Sep; 154(9):1316. PubMed ID: 9286196
    [No Abstract]   [Full Text] [Related]  

  • 16. [Akathisia--diagnosis, pathophysiology and therapy].
    Zyss T; Banach M; Zieba A
    Psychiatr Pol; 2009; 43(4):387-402. PubMed ID: 20128247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for the development of neuroleptic induced akathisia.
    Miller CH; Hummer M; Oberbauer H; Kurzthaler I; DeCol C; Fleischhacker WW
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):51-5. PubMed ID: 9088885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polysomnographic study on periodic limb movements in patients with restless legs syndrome and neuroleptic-induced akathisia.
    Inami Y; Horiguchi J; Nishimatsu O; Sasaki A; Sukegawa T; Katagiri H; Yamawaki S
    Hiroshima J Med Sci; 1997 Dec; 46(4):133-41. PubMed ID: 9538563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of efficacy of d-propranolol in neuroleptic-induced akathisia.
    Adler LA; Angrist B; Fritz P; Rotrosen J; Mallya G; Lipinski JF
    Neuropsychopharmacology; 1991 Feb; 4(2):109-15. PubMed ID: 1673844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label olanzapine treatment in five preadolescent children.
    Krishnamoorthy J; King BH
    J Child Adolesc Psychopharmacol; 1998; 8(2):107-13. PubMed ID: 9730076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.